Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

GH Research, Compass Pathways Among Top Psychedelic Movers Of Today

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 14.78% at $6.91 Compass Pathways (NASDAQ:CMPS) shares closed up 5.88% at…
byBenzinga Insights
March 23, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

GAINERS:

  • GH Research (NASDAQ:GHRS) shares closed up 14.78% at $6.91
  • Compass Pathways (NASDAQ:CMPS) shares closed up 5.88% at $10.08
  • Cybin (AMEX:CYBN) shares closed up 2.61% at $0.41
  • Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.13% at $0.69
  • ATAI Life Sciences (NASDAQ:ATAI) shares closed up 1.71% at $1.19
  • Mind Medicine (NASDAQ:MNMD) shares closed up 1.59% at $2.88

LOSERS:

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Mydecine’s Prospectus Supplement Closing Under Share Subscription And Management Update

By Lara Goldstein
May 30, 8:30 PM
Colorado-based next-generation psychedelics biotech Mydecine Innovations Group Inc. (OTC: MYCOF) announced that, in connection with its common share subscription agreement with a third-party investor dated this past March 10, it has filed a shelf prospectus supplement to its final base shelf prospectus for th

MYCOF